Facetten
Zugriff
Einrichtung
Medientyp
- Text 5
Karte
Erscheinungsjahr
Autor/in
- Engelhardt, Monika
- Weisel, Katja
- Anderson, Larry D 2
- Corso, Alessandro 2
- Einsele, Hermann 2
- alle zeigen
Sprache
- Englisch 5
5 Einträge gefunden
-
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial
- Weisel, Katja
- Dimopoulos, Meletios A
- San-Miguel, Jesús
- Paner, Agne
- Engelhardt, Monika
- Taylor, Fiona
- Lord-Bessen, Jennifer
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics
- Richardson, Paul G
- Schjesvold, Fredrik
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- Rodriguez-Otero, Paula
-
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse
- Dimopoulos, Meletios
- Weisel, Katja
- Moreau, Philippe
- Anderson, Larry D
- White, Darrell
- San-Miguel, Jesus
- Sonneveld, Pieter
-
-
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
- Raab, Marc S
- Engelhardt, Monika
- Blank, Antje
- Goldschmidt, Hartmut
- Agis, Hermine
- Blau, Igor W
- Einsele, Hermann